This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg, Germany

Guillaume Jacquot, PharmD, Ph.D
Program Director, Brain & Tissue Delivery of Oligonucleotides at VECT-HORUS S.A.S.
Speaker

Profile

Dr. Guillaume JACQUOT is Doctor of Pharmacy and got his PhD in cellular biology. He brings 20 years of academic and industrial experience in multi-disciplinary scientific project management and translational research in various fields, including intracellular trafficking, virology, cardiovascular, neurobiology and cancer. His expertise extends from early discovery and hit-to-lead optimization to regulatory pharmacology and preclinical/early clinical development. He joined VECT-HORUS in 2010 where he created and manages a team dedicated to both intracellular pharmacokinetics (ICPK) profiling of molecular conjugates targeting endocytic receptors and in vivo evaluation of PK and pharmacological properties of lead candidates. Since 2016, he is leading efforts to apply and optimize VECT-HORUS’ VECTrans® drug targeting technology to therapeutics oligonucleotides to explore and implement their full potential in clinics based on industrial partnerships.

Agenda Sessions

  • TfR-targeted Functional Delivery of Oligonucleotides to CNS Tissues by Local and Systemic Administration

    15:30